The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Possible predictive value of G8 score and the drug concentrations for efficacy and toxicity of trifluridine/tipiracil for elderly patients with advanced colorectal cancer: A multicenter, phase II study (T-CORE1401).
 
Masanobu Takahashi
Honoraria - Chugai Pharma; Daiichi Sankyo; Kirin Pharmaceuticals; Lilly Japan; Merck Serono; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Pharmaceutical
Research Funding - Ono Pharmaceutical (Inst)
 
Makio Gamoh
Honoraria - Bayer; Merck; Nippon Kayaku; Ono Pharmaceutical; Shionogi; Taiho Pharmaceutical; Takeda
 
Hisatsugu Ohori
No Relationships to Disclose
 
Yasuhiro Sakamoto
No Relationships to Disclose
 
Yasushi Tsuji
Honoraria - Bayer; Chugai Pharma; Daiichi Sankyo; Eisai; Kyowa Hakko Kirin; Lilly Japan; Medicon; Merck Serono; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Michio Kuroki
No Relationships to Disclose
 
Masahiro Takahashi
No Relationships to Disclose
 
Hiroko Yaegashi
No Relationships to Disclose
 
Hiroaki Yamaguchi
No Relationships to Disclose
 
Takuhiro Yamaguchi
Consulting or Advisory Role - CAC Croit Corporation; Chugai Pharma; Japan Tobacco Inc; Kowa; Ono Pharmaceutical; TSUMURA & CO.
Research Funding - A2 Healthcare (Inst); AC Medical (Inst); CAC Croit Corporation (Inst); Facet Biotech (Inst); Japan Media Corporation (Inst); Japan Tobacco Inc (Inst); Kyowa Hakko Kirin (Inst); Luminary Medical (Inst); Medidata Solutions, Inc (Inst); Ono Pharmaceutical (Inst)
 
Hideki Shimodaira
No Relationships to Disclose
 
Takashi Yoshioka
No Relationships to Disclose
 
Chikashi Ishioka
Honoraria - Asahi Kasei; AstraZeneca; Bayer; Chugai Pharma; Daiichi Sankyo; Eisai; Lilly Japan; Merck Serono; Mochida Pharmaceutical Co. Ltd.; Nihonkayaku; Nipro Corporation; Novartis; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Asahi Kasei (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Kissei Pharmaceutical (Inst); Kyowa Hakko Kirin (Inst); Lilly Japan (Inst); Merck Serono (Inst); Mochida Pharmaceutical Co. Ltd. (Inst); MSD K.K (Inst); Nihonkayaku (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Tsumura & Co. (Inst); Yakult Honsha (Inst)